Table 2.

Clinical characteristics of patients

Patient (Code)	Group	Age	Sex	ALS-FRS-R Score	FVC	Disease duration at entry	Follow up duration
					(%)	(Months from symptoms onset)	(Months from surgery to death (†) or to the last visit)
740	A1	30	M	25	74	60	18
746	A1	57	M	28	64	68	8†
753	A1	54	F	29	83	16	8†
766	A2	35	M	30	82	72	12
767	A2	67	F	35	88	36	8†
779	A2	38	M	24	82	24	7

A1; unilateral hNSCs microinjections.

A2; bilateral hNSCs microinjections.

†; death.